Insider Transactions in Q1 2021 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 09
2021
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
961
-13.72%
|
$154,721
$161.5 P/Share
|
|
Mar 08
2021
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,089
-13.45%
|
$175,329
$161.61 P/Share
|
|
Mar 08
2021
|
Finbar Larkin SVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
1,509
-8.37%
|
$242,949
$161.6 P/Share
|
|
Mar 05
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,516
-6.21%
|
$3,528,624
$164.75 P/Share
|
|
Mar 05
2021
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-2.4%
|
$121,524
$164.75 P/Share
|
|
Mar 05
2021
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
691
-2.57%
|
$113,324
$164.75 P/Share
|
|
Mar 05
2021
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,402
-10.49%
|
$229,928
$164.75 P/Share
|
|
Mar 05
2021
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,718
-6.93%
|
$609,752
$164.75 P/Share
|
|
Mar 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
9,600
-2.7%
|
$1,632,000
$170.0 P/Share
|
|
Feb 25
2021
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,590
+50.0%
|
-
|
|
Feb 25
2021
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,590
+50.0%
|
-
|
|
Feb 25
2021
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,895
+18.97%
|
-
|
|
Feb 25
2021
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,925
+9.63%
|
-
|
|
Feb 25
2021
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+27.35%
|
-
|
|
Feb 25
2021
|
Robert Iannone EVP, Global Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
8,535
+21.65%
|
-
|
|
Feb 25
2021
|
Finbar Larkin SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,950
+17.97%
|
-
|
|
Feb 25
2021
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,270
+21.31%
|
-
|
|
Feb 25
2021
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,160
+19.13%
|
-
|
|
Feb 25
2021
|
Kim Sablich EVP, GM of U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
8,535
+25.2%
|
-
|
|
Feb 25
2021
|
Daniel N Swisher Jr President and COO |
BUY
Grant, award, or other acquisition
|
Direct |
11,695
+17.89%
|
-
|
|
Feb 03
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
250
-0.08%
|
$40,000
$160.0 P/Share
|
|
Feb 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,250
-0.39%
|
$195,000
$156.15 P/Share
|
|
Jan 04
2021
|
Daniel N Swisher Jr President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,607
-3.69%
|
$257,120
$160.4 P/Share
|
|
Jan 04
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,950
-2.43%
|
$1,287,900
$162.01 P/Share
|